Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects
Clinical trial NCT00310596 · COMPLETED
Trial details
- NCT number
- NCT00310596
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.